US Retail Pharmacy Market Sample Report 2022 to 2030

1. A sample report on US Retail Pharmacy Market Analysis

2. This report presents a strategic analysis of the US Retail Pharmacy Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, main players, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the US Retail Pharmacy Market, and offers unmatched value, accuracy, and expert insights.

3. Report Scope Click on the icon to know the detailed methodology

4. Table of Content

5. Table of Content

6. Table of Content

7. 1. Market Overview

8. 1.1 US Retail Pharmacy Overview • Diverse landscape of US retail pharmacies, includes independents and chains like CVS Health, Walgreens, and Rite Aid, which are vital for dispensing prescriptions and providing health-related products • Pharmacists ensure accuracy, offer counseling, and monitor for drug interactions. Retail pharmacies leverage technology for online refills and mobile medication management. Despite challenges, they are indispensable to healthcare, contributing to community well-being and meeting strict regulatory standards • Key services provided by retail pharmacies include: • Prescription Dispensing: The primary function of retail pharmacies is to dispense prescription medications prescribed by healthcare professionals • Over-the-Counter (OTC) Products: Retail pharmacies stock a wide range of over-the-counter medications, vitamins, supplements, and personal care items • Pharmacist Consultations: Pharmacists are available to provide consultations and advice on medications, potential side effects, and proper usage • Immunizations: Many retail pharmacies offer vaccination services, including flu shots and other routine immunizations • Online Prescription Refills: Many pharmacies have online platforms or mobile apps that allow customers to request prescription refills and manage their medications digitally • Home Delivery: Some retail pharmacies provide home delivery services, ensuring that medications reach patients who may have difficulty visiting the pharmacy in person

9. 1.2 Healthcare Scenario in the World Regional Analysis • Africa: $_ _ • APAC: $_ _ • Europe: $_ _ • LATAM: $_ _ • Middle East: $_ _ • North America: $_ _ US Market ~$xx Bn Market Illustrative

10. 1.3 US Overview • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In this section you will get an understanding of the topic, which includes the prevalence of the disease, the application of medical devices, new technology, and other details related to the topic • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest 38.1 years Is the median age in the US $26.24 Tn Is the Gross Domestic Product of US in 2023 16.6% Of US GDP is spent on healthcare 339 Mn Population of US in 2023 Illustrative

11. 1.4 Economic Overview: US US Population (in Mn) US GDP (in $Tn) US Population Split (2023) • In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, healthcare expenditure and other details related to the topic • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest By Gender By Age Group 0-14 15-24 25-54 55-64 65+ Illustrative

12. 1.5 Statistics at a Glance: US Retail Pharmacy Market • In this section you will get an understanding of the scope of US Retail Pharmacy Market and other details related to the topic • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest 3.5% There is an increase of 3.5% from 2022 in Pharmacies & Drug Stores businesses in the US 44,900 There are 44,900 Pharmacies & Drug Stores businesses in the US as of 2023 313,799 Currently, there are more than 313,799 pharmacists actively working in the US 56.8% Women make up 56.8% of the total pharmacist population, whereas men constitute 43.2% Illustrative

13. 1.6 US Healthcare Market • US Healthcare Market Forecast, 2022-2030 (in $Bn) • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In this section you will get an understanding of the overall Global Clinical Trial Patient Recruitment Services Market, which includes the market size, current trends and other details related to the topic • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative

14. 1.7 US Healthcare Scenario Public Healthcare • US healthcare system, characterized by its complexity and distinctiveness, is primarily private, with employer-sponsored health insurance covering approximately half the population through diverse plans offered by private insurers • Public programs such as Medicare, Medicaid, and CHIP complement efforts to provide healthcare coverage, yet a significant number of individuals, especially low-income adults and those in non-traditional jobs, remain uninsured Private Healthcare • US private healthcare sector, covering about half the population, involves key players like insurance companies, healthcare providers, employers, and individual consumers • Potential developments include cost control measures, expanding health insurance exchanges, exploring alternative insurance models, and integrating technology like telemedicine and AI for efficiency and affordability Insurance • US insurance landscape encompasses coverage from private companies, including Property & Casualty (P&C), Life Insurance, Health Insurance, Long-Term Care Insurance, and Disability Insurance • Private firms lead US insurance, tackling challenges through state regulations and programs like Medicare and Medicaid Government Programs • US government programs, spanning social safety nets, infrastructure, healthcare, and education, face challenges like budget constraints and administrative inefficiencies • Key programs, including Social Security and Medicare, target support for various demographics. Encouraging public engagement is crucial for accountability and responsive program oversight Illustrative

15. 1.8 Budget of US Government for Public Insurance • National Health Expenditures (NHE) grew 2.7% to $4.3 Tn in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP) • Medicare spending grew 8.4% to $900.8 Bn in 2021, or 21% of total NHE • Private health insurance spending grew 5.8% to $1,211.4 Bn in 2021, or 28% of total NHE • Out of pocket spending grew 10.4% to $433.2 Bn in 2021, or 10% of total NHE • Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 Bn, or 14% of total NHE • Hospital expenditures grew 4.4% to $1,323.9 Bn in 2021, slower than the 6.2% growth in 2020 • Physician and clinical services expenditures grew 5.6% to $864.6 Bn in 2021, slower growth than the 6.6% in 2020 • Prescription drug spending increased 7.8% to $378.0 Bn in 2021, faster than the 3.7% growth in 2020 • Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7% Illustrative

16. 1.9 Top Developments in US Market Latest Deals in US Illustrative

17. 1.9 Top Developments in US Market (Continued) Latest Deals in US Illustrative

18. 2. Types of Retail Pharmacy

19. 2.1 Types of Retail Pharmacy Independent Pharmacies Discount Pharmacies Compounding Pharmacies Specialty Pharmacies Chain Pharmacies • Retailfranchiseswith multiplelocations acrossstatesor countries • Oftenpartofa national orinternationalbrand • Widespreadpresence, makingthemeasily accessible • Typicallya standardized look,feel,andservice • Locallyownedand operatedbusinessess, oftenrunby pharmacistsactivelyinvolvedintheday-to-dayoperations • Oftenpridethemselves on providing personalizedand attentivecustomer service • Focusonprovidinglow-costgeneric medications • Limitedselectionof productscomparedto largerchainpharmacies • Businessmodel revolvesaroundcost-savingstrategiesto provideaffordable healthcareoptions • Caterstopatientswith complexandchronic conditions • Offeringraredifficult-to- findmedications • Providecomprehensive clinicalsupport, includingpatient education,counseling, andmonitoring • Createcustomized medicationstailoredto meettheuniqueneeds ofindividualpatients • Preparemedicationsin specificformsor dosagesthatarenot commerciallyavailable, addressingpatient- specificrequirementsor allergies

20. 3. Market Size and Forecasting

21. 3.1 Market size and forecasts (Excel and Methodology) • US Retail Pharmacy Market Forecast, 2022-2030 • In this section you will get an understanding of the US retail pharmacy market, which includes the major market patients, the patient size, the percentage of patients, the US market size, and other details related to the topic • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest CAGR~ XX% Click on the icon to know the calculations and assumption Illustrative

22. 3.2 Snapshot of US Retail Pharmacy Market Segmentation TypeofProduct TypeofPharmacy Indication OTCProducts Chain Cardiology PrescriptionMedicine Independent Oncology CompoundedMedicine Nephrology Others FoodSupplements Endocrinology Cosmetics Psychiatry Others • In this section you will get an understanding of the segmentations which will cover the US Retail Pharmacy Market • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Illustrative

23. 3.2.1 Market Segmentation: By Type of Product • In this section you will get an understanding of US retail pharmacy market segmentation by type of product • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest US Retail Pharmacy Market Share, By Type of Product (2023) Illustrative

24. 3.2.2 Market Segmentation: By Type of Pharmacy • In this section you will get an understanding of US retail pharmacy market segmentation by type of pharmacy • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest US Retail Pharmacy Market Share, By Type of Pharmacy(2023) Illustrative

25. 3.2.3 Market Segmentation: By Indication • In this section you will get an understanding of US retail pharmacy market segmentation by Indication • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest US Retail Pharmacy Market Share, By Indication (2023) Illustrative

26. 4. Market Dynamics

27. 4.1 Snapshot Of Market Growth Drivers And Restraints 4.1.3 4.1.2 4.1.1 Aging population drives retail pharmacy growth Widespread pharmacy chain presence extends market potential Tech upgrades in tele pharmacy, online orders, and home delivery enhance access, driving market growth 4.2.1 4.2.2 High drug prices can deter people from obtaining prescribed medications, affecting overall market growth Government and insurance measures to cut healthcare costs can impact pharmacy profits and services Illustrative

28. 4.1.1 Retail pharmacies surge as aging population hits 58 Mn, anticipating 82 Mn by 2050 • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Aging Population in US (in Mn) Illustrative

29. 4.1.2 US pharmacies and drug stores surge to 44,900 in 2023, marking a 3.5% YoY increase, fueled by growing presence in retail chains and supermarkets • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Increase in US Pharmacies and Drug Stores xx% Illustrative

30. 4.1.3 US online pharmacy sector hits $5.7 Bn, emerges as leading market with tech innovations driving growth • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest US Online Pharmacy Revenue (in Bn) Illustrative

31. 4.2 Market Restraints 4.2.2 Government and insurance measures to cut healthcare costs can impact pharmacy profits and services 4.2.1 High drug prices can deter people from obtaining prescribed medications, affecting overall market growth • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Our analysis will thoroughly investigate the key restraints that may significantly impact business operations and growth. Illustrative

32. 5. Competitive Landscape

33. 5.1 Major Market Share • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In this section you will the understating of financial overview of the company, which includes revenue forecasting, segment revenue and other key details as per availability • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Revenue of Major Players in US Retail Pharmacy Market ($ Mn) Illustrative

34. 5.2 Key Players in US Retail Pharmacy Market • Here is the list of top 10 companies which will cover in the final report • Each company will have slides for • Overview • Key details • Offerings • Name of products • Recent activities/ Press Coverage • Distribution and Vendor Partners • Mergers, Acquisitions and Collaboration • Financials • If there are specific companies that you would like to be included in the report, please let us know via email • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Global Player Local Player 1 6 CVS Health Walmart Inc 2 7 Walgreens Boots Alliance Medplus 3 8 UnitedHealth Group Rite Aid Corp 4 9 Rowland Pharmacy Walvax Biotechnology 5 10 The Kroger Co Tesco Illustrative

35. 5.2.1 CVS Health Founded in: 1963 HQ:Woonsocket, United States Type: Private Revenue: $357.8 Bn Website: cvshealth.com • CVS Health is constructing a comprehensive health ecosystem for every consumer, providing accessible and affordable healthcare through various channels • As a prominent health solutions company, we ensure high-quality, personalized care with a tech-forward approach • With a widespread community presence and engagement with over 100 Mn people, they aim to deliver healthcare tailored to individual needs, both locally and nationally Recent Activity / Press Coverage

36. 5.2.1 CVS Health (Continued) Latest Deals - Mergers and Acquisitions Illustrative

37. 5.2.1 CVS Health (Continued) • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In this section you will the understating of financial overview of the company, which includes revenue forecasting, segment revenue and other key details as per availability • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Revenues ($Bn), 2020-2030 Breakdown of Net Revenue by Segment, 2023 Illustrative

38. 5.2.2 Company 2 Founded in: HQ: Type: Revenue: Website: Drugs for Telemedicine Recent Activity / Press Coverage

39. 5.2.2 Company 2 (Continued) Partnerships Ecosystem Major Vendor Partners Major Distribution Partners

40. 5.2.2 Company 2 (Continued) Latest Deals - Mergers and Acquisitions

41. 5.2.2 Company 2 (Continued) • Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report • In this section you will the understating of financial overview of the company, which includes revenue forecasting, segment revenue and other key details as per availability • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Revenues ($Bn), 2020-2030 Breakdown of Net Revenue by Segment, 2022

42. 6. Reimbursement Scenario

43. 6.1 Reimbursement Regulation in US Regulatory Authorities With Jurisdiction Over Retail Pharmacy • In the US, regulatory oversight of retail pharmacy is primarily managed by: • Food and Drug Administration (FDA): Federal agency under the Department of Health and Human Services. Ensures the safety and effectiveness of prescription and over-the-counter medications • Drug Enforcement Administration (DEA): A division of the US Department of Justice. Regulates controlled substances, including certain prescription medications with potential for abuse. • Centers for Medicare & Medicaid Services (CMS): Federal agency within the Department of Health and Human Services. Administers Medicare and Medicaid programs, influencing reimbursement policies and regulations for pharmacies. • State Boards of Pharmacy:Each state has its own Board of Pharmacy. Regulates and licenses pharmacists and pharmacies within the state. Enforces state-specific pharmacy laws and regulations. • Pharmacy Benefit Managers (PBMs): While not regulatory authorities, PBMs play a significant role in the pharmacy industry. Administer prescription drug plans for insurance companies and employers, influencing drug pricing and formulary management. Illustrative

44. 6.1 Reimbursement Regulation in US Regulatory Framework For The Authorization, Pricing, And Reimbursement of Retail Pharmacy • In the US, the regulatory framework for the authorization, pricing, and reimbursement of retail pharmacies involves: • Authorization and Licensing: Oversight is provided by State Boards of Pharmacy, which regulate and license retail pharmacies and pharmacists. Adherence to state-specific regulations is crucial for authorization • Pricing: Centers for Medicare & Medicaid Services (CMS) play a pivotal role in determining pricing, particularly for medications covered by government programs like Medicare and Medicaid. Pharmacy Benefit Managers (PBMs) negotiate drug prices with manufacturers and establish reimbursement rates for pharmacies, exerting significant influence on pricing dynamics • Reimbursement: CMS and Medicaid set reimbursement rates for prescription medications dispensed by retail pharmacies, impacting the financial aspects of pharmacy services. Private insurance companies negotiate reimbursement rates with pharmacies, contributing to the overall financial landscape for retail pharmacy services • Drug Enforcement Administration (DEA): The DEA, under the US Department of Justice regulates controlled substances, and compliance is essential for pharmacies handling and dispensing prescription medications • Health Insurance Portability and Accountability Act (HIPAA): HIPAA regulations are crucial for patient data protection and privacy. Patient recruitment services must comply with HIPAA requirements when handling and managing sensitive patient information • State Health Departments: State health departments may introduce additional regulations related to public health, emergency preparedness, and other factors influencing retail pharmacy operations Illustrative

45. 6.1 Reimbursement Regulation in US (Continued) Coverage Penetration (% Total Population) Source of Funding Spend on Healthcare (%of Current Health Expenditure) • Public healthcare coverage is provided by the government and includes programs like Medicare and Medicaid • Medicare is a federal program that provides healthcare coverage to individuals who are 65 years of age or older, as well as certain younger people with disabilities Reimbursement Market Trends • Shift towards value-based care has been a significant trend in Saudi Arabia healthcare system, with payers and providers increasingly focused on improving patient outcomes and reducing costs • This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which incentivize providers to deliver high-quality, cost-effective care Illustrative

46. 6.2 Reimbursement Process • The reimbursement process in US healthcare system can be complex and can vary depending on the type of healthcare service, the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process: • Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient • Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the service provided • Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential errors or fraud • Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service provided, based on the negotiated payment rates or fee schedule • Patient Responsibility: Depending on the patient's insurance coverage, they may be responsible for paying a portion of the cost of the service, such as deductibles, co-payments, or co-insurance • In order to obtain access to all of the information that you are seeking, you will need to purchase the final report • Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Illustrative

47. 6.3 Reimbursement Process (Continued) • The reimbursement process in US healthcare system can be complex and can vary depending on the type of healthcare service, the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process: • Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient • Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the service provided • Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential errors or fraud • Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service provided, based on the negotiated payment rates or fee schedule MoH Market Authorization Private Payers Public Payers Health Technology Assessment Coding Coverage Payment 1 2 3 Coding depends on availability code while coverage and payment process decisions are made through an HTA. Illustrative

48. A division of

49. Life-sciences Market Research Reports you can trust • We maintain an extensive database comprising over 30,000 syndicated market research reports within the pharmaceuticals and healthcare sector, offering a global, regional, and country-level perspective. Our services also include the provision of customized research reports, meticulously tailored to align with your specific requirements. www.insights10.com

50. Pharma (Diseases & Drugs) Digital Health OTC & Nutraceuticals Medical Devices Clinical Trials Healthcare Services Rare Diseases • Market Research Reports across various categories in healthcare • At Insights10, our extensive report library spans a diverse range of categories within the field of life sciences. www.insights10.com